Grifols (GIFLF) FCF Margin Growth (3y) (2013 - 2020)
Powered by 
Analysis
Grifols (GIFLF) FCF Margin Growth (3y) (2013 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | -2,024.00 |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 1,067.00 |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | -1,272.00 |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | -2,228.00 |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | -5,426.00 |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 4,612.00 |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | -203.00 |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | -1.75 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | -555.00 |
| Dec 31, 2019 | -17.00 |
| Dec 31, 2018 | -1,668.00 |
| Jun 30, 2018 | -821.00 |
| Mar 31, 2018 | 531.00 |
| Dec 31, 2017 | 431.00 |
| Jun 30, 2017 | 1.53 Mn |
| Mar 31, 2017 | -195.00 |
| Dec 31, 2016 | -138,959.00 |
| Sep 30, 2016 | 777.00 |
| Dec 31, 2015 | -92,002.00 |
| Sep 30, 2015 | -275.00 |
| Jun 30, 2015 | 175.00 |
| Mar 31, 2015 | -821.00 |
| Dec 31, 2014 | -1,374.00 |
| Sep 30, 2014 | 7,147.00 |
| Jun 30, 2014 | -1.53 Mn |
| Mar 31, 2014 | -105.00 |
| Dec 31, 2013 | 138,597.00 |
| Sep 30, 2013 | 3,276.00 |